Clinical trials: Cue-reactivity

Alcohol Dependence

Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent

• Completed
• Age: 21 to 65 years
• Phase 1/2
• Pill or oral medicine

Examination of the effect of GET 73 on alcohol pharmacokinetics and pharmacodynamics (intoxication and sedation)and safety profile in alcohol-dependent individuals.To evaluate whether GET 73, as compared to placebo, results in…

Trial name

SPAD (NCT01842503)

Testing

GET 73, inactive ingredients capsule

Where

United States

Volunteers

25 people

Sponsor

Laboratorio Farmaceutico Ct S.r.l.